Company: CRNX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-029050
Chunk: 42

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 42
---
-K

    3/30/2022

    10.18

    10.23#
     
    Employment Agreement, effective as of September 13, 2021, by and between Jeff Knight and the Registrant
     
    10-K

    3/30/2022

    10.19

    10.24#
     
    Consulting Agreement, effective as of October 15, 2024, between Crinetics Pharmaceuticals, Inc. and James Hassard 
     
    8-K

    10/16/2024

    10.1

    10.25#
     
    Separation and Release Agreement, dated October 10, 2024, between Crinetics Pharmaceuticals, Inc. and James Hassard. 
     
    8-K

    10/16/2024

    10.2

    10.26#
     
    Employment Agreement, effective as of September 30, 2022, by and between Dana Pizzuti and the Registrant
     
    10-Q

    11/14/2022

    10.2

    10.27#
     
    Employment Agreement, effective December 16, 2024, by and between Isabel Kalofonos and the Registrant

    X

    10.28#
     
    Sales Agreement, dated June 21, 2024, by and among Crinetics Pharmaceuticals, Inc., Leerink Partners LLC and Cantor Fitzgerald & Co.
     
    8-K

    6/21/2024

    1.1

    10.29#
     
    Registration Rights Agreement, dated February 27, 2024, by and among Crinetics Pharmaceuticals, Inc. and the persons party thereto.
     
    8-K

    3/1/2024

    10.2

    10.30† 
     
    License Agreement, dated as of February 25, 2022, by and between Sanwa Kagaku Kenkyusho Co., Ltd. and the Registrant
     
    10-Q

    5/12/2022

    10.2

    19
     
    Insider Trading Compliance Policy
     
    10-K

    2/28/2024

    19

    21.1